Related Experiment Video
Updated: Mar 10, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Diagnosis of growth hormone deficiency in the paediatric and transitional age
1Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Central Manchester Foundation Hospitals NHS Trust, Manchester, UK.
Insights
Diagnosing growth hormone deficiency in children requires careful consideration of auxology, biochemistry, and imaging. Growth hormone provocation tests are key but need cautious interpretation due to variability and limited evidence.
Area of Science:
- Pediatric Endocrinology
- Growth Disorders
Background:
- Growth hormone deficiency (GHD) is a rare cause of short stature in children.
- Treatment is available using recombinant human growth hormone (rhGH).
Purpose of the Study:
- To review the diagnostic approaches for GHD in children.
- To highlight the challenges and limitations in current diagnostic methods.
Main Methods:
- Review of auxological, biochemical, and imaging data.
- Discussion of growth hormone (GH) provocation tests and their limitations.
- Consideration of assay difficulties, pituitary MRI, and genetic testing.
Main Results:
- No definitive gold standard exists for GHD diagnosis.
- GH provocation tests show variability and reproducibility issues.
- Pituitary MRI and genetic testing are increasingly important diagnostic aids.
Conclusions:
- Diagnosis relies on a combination of methods, interpreted with caution.
- Nutritional and pubertal status impact test results.
- Children with GHD are re-evaluated in adulthood.
Abstract:
Growth hormone deficiency is a rare cause of childhood short stature, but one for which treatment exists in the form of recombinant human growth hormone. A diagnosis of growth hormone deficiency is made based on auxology, biochemistry and imaging. Although no diagnostic gold standard exists, growth hormone provocation tests are considered the mainstay of diagnostic investigations. However, these must be interpreted with caution in view of issues with variability and reproducibility, as well as the limited evidence-base for cut-off values used to distinguish growth hormone deficient and non-growth hormone deficient subjects. In addition, nutritional and pubertal status can affect results, with no consensus on the role of priming with sex steroid hormones. Difficulties with assays exist both for growth hormone as well as insulin-like growth factor-1. Pituitary magnetic resonance imaging is a useful diagnostic, and possibly prognostic, aid. Although genetic testing is not routine, the discovery of more relevant mutations makes it an increasingly important investigation. Children with growth hormone deficiency are retested biochemically on completion of growth, to assess whether they remain so into adulthood.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Signs of Puberty
Pharmacokinetics in Pediatric Patients: Drug Excretion
Hypoglycemia and Glucagon
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Drug Dosing: Infants and Children

